In our work, we spend much time examining companies’ operating models and organizational structures. Many that we talk to have not taken a deliberate, planned approach to designing their models, ...

Pharma is entering a period of structural change in how innovation is converted into patient impact. Commercial models that were highly effective for decades built around scale, promotion, and ...